Blended transdiagnostic group CBT for emotional disorders: A feasibility trial protocol.
Anxiety
Blended CB
Blended psychotherapy
Depression
Emotional disorders
Group psychotherapy
Transdiagnostic
Journal
Internet interventions
ISSN: 2214-7829
Titre abrégé: Internet Interv
Pays: Netherlands
ID NLM: 101631612
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
25
10
2020
revised:
21
12
2020
accepted:
29
12
2020
entrez:
1
2
2021
pubmed:
2
2
2021
medline:
2
2
2021
Statut:
epublish
Résumé
Emotional disorders (anxiety and depressive disorders) are a relevant public health concern associated with high prevalence, high costs, and important disability. Therefore, research priorities include designing and testing cost-effective interventions to reach everyone in need. Internet-delivered interventions for emotional disorders are effective and can help to disseminate and implement evidence-based treatments. However, although these treatments are generally effective, not all patients benefit from this treatment format equally. Blended treatments are a new form of intervention that combines the strengths of face-to-face and Internet approaches. Nevertheless, research on blended interventions has focused primarily on individual therapy, and less attention has been paid to the potential of using this format in group psychotherapy. This study aims to analyze the feasibility of blended transdiagnostic group CBT for emotional disorders. The current article describes the study protocol for this trial. A one-armed pilot trial will be conducted. Participants will be 30 adults suffering from DSM-5 anxiety and/or depressive disorders. The treatment consists of a blended transdiagnostic group intervention delivered during a period of 24 weeks. Groups of 6 to 10 patients will attend a total of eight 2-hour, face-to-face sessions, alternated with the use of an online platform where they will find the contents of the treatment protocol. The intervention has four core components: present-focused awareness, cognitive flexibility, identification and modification of behavioral and cognitive patterns of emotional avoidance, and interoceptive and situational exposure. These components are delivered in 16 modules. Assessments will be performed at baseline, during the treatment, at post-treatment, and at 3-month follow-up. Clinical and treatment acceptability outcomes will be included. Quantitative and qualitative data (participants' views about blended group psychotherapy) will be analyzed. The trial has received ethical approval from the Ethics Committee of Universitat Jaume I (September 2019) and will be conducted in accordance with the study protocol, the Declaration of Helsinki, and good clinical practice. The results of this study will be disseminated by presentation at conferences and will be submitted for publication in a peer-reviewed journal. ClinicalTrials.gov Identifier: NCT04008576. Registered 05 July 2019, https://clinicaltrials.gov/ct2/show/NCT04008576.
Identifiants
pubmed: 33520670
doi: 10.1016/j.invent.2021.100363
pii: S2214-7829(21)00003-8
pmc: PMC7820549
doi:
Banques de données
ClinicalTrials.gov
['NCT04008576']
Types de publication
Journal Article
Langues
eng
Pagination
100363Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
BMJ. 2011 Jul 26;343:d4163
pubmed: 21791490
Nature. 2011 Jul 06;475(7354):27-30
pubmed: 21734685
Psychol Assess. 2014 Sep;26(3):815-830
pubmed: 24708078
Eur J Neurol. 2005 Jun;12 Suppl 1:39-44
pubmed: 15877777
Int J Qual Health Care. 2007 Dec;19(6):349-57
pubmed: 17872937
PLoS One. 2018 Nov 1;13(11):e0206516
pubmed: 30383797
J Med Internet Res. 2017 Sep 15;19(9):e306
pubmed: 28916506
Behav Ther. 2016 Nov;47(6):838-853
pubmed: 27993336
J Nerv Ment Dis. 2000 May;188(5):301-5
pubmed: 10830568
J Anxiety Disord. 2016 Apr;39:44-64
pubmed: 26953823
Behav Ther. 2018 Nov;49(6):939-950
pubmed: 30316492
BMC Psychiatry. 2020 Feb 10;20(1):56
pubmed: 32039720
Trials. 2016 Aug 03;17(1):387
pubmed: 27488181
Br J Psychiatry. 2002 May;180:461-4
pubmed: 11983645
BMC Psychiatry. 2014 Oct 18;14:290
pubmed: 25326035
J Med Internet Res. 2020 Jul 7;22(7):e18220
pubmed: 32673226
Bull World Health Organ. 2004 Nov;82(11):858-66
pubmed: 15640922
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
Int J Eat Disord. 2013 Jul;46(5):386-94
pubmed: 23658076
J Affect Disord. 2016 Jul 15;199:30-41
pubmed: 27060430
PLoS One. 2018 Nov 15;13(11):e0207396
pubmed: 30440020
J Affect Disord. 2009 Jan;112(1-3):92-101
pubmed: 18486238
Pediatrics. 2010 Nov;126(5):e1153-60
pubmed: 20921066
Behav Res Ther. 2011 Aug;49(8):441-52
pubmed: 21679925
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
PLoS One. 2016 Feb 17;11(2):e0148237
pubmed: 26886423
Clin Psychol Rev. 2012 Jun;32(4):329-42
pubmed: 22466510
Cogn Behav Ther. 2014;43(3):171-84
pubmed: 24646219
Behav Ther. 2017 Jan;48(1):128-138
pubmed: 28077216
J Pers Soc Psychol. 1988 Jun;54(6):1063-70
pubmed: 3397865
Psychol Med. 2014 Aug;44(11):2363-74
pubmed: 24451993
J Health Serv Res Policy. 2008 Apr;13(2):92-8
pubmed: 18416914
PLoS Med. 2013 Nov;10(11):e1001547
pubmed: 24223526
Neuropsychiatr Dis Treat. 2017 Mar 31;13:987-1006
pubmed: 28408833
JAMA. 2012 Mar 14;307(10):1033-4
pubmed: 22416097
J Psychosoc Nurs Ment Health Serv. 2019 May 1;57(5):44-51
pubmed: 30508459
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
Behav Res Ther. 2010 Sep;48(9):890-9
pubmed: 20561606
Depress Anxiety. 2017 Mar;34(3):267-280
pubmed: 28060463
Acta Psychiatr Scand. 2011 May;123(5):387-97
pubmed: 20946200
PLoS One. 2010 Oct 13;5(10):e13196
pubmed: 20967242
JMIR Ment Health. 2016 Feb 09;3(1):e9
pubmed: 26860537
Am J Prev Med. 2009 May;36(5):452-7
pubmed: 19362699
Neuropsychiatr Dis Treat. 2018 Mar 28;14:879-892
pubmed: 29636613
Arch Gen Psychiatry. 2005 Jun;62(6):593-602
pubmed: 15939837
Lancet Psychiatry. 2015 Nov;2(11):1036-42
pubmed: 26404415
Health Qual Life Outcomes. 2018 Mar 12;16(1):46
pubmed: 29530035
Lancet. 2007 Sep 8;370(9590):841-50
pubmed: 17826169
Implement Sci. 2012 May 31;7:50
pubmed: 22651257
Eur J Public Health. 2015 Apr;25(2):249-54
pubmed: 25678606
Int J Epidemiol. 2014 Apr;43(2):476-93
pubmed: 24648481
BMJ Open. 2018 Mar 12;8(3):e018412
pubmed: 29530905
BMC Psychiatry. 2017 Apr 20;17(1):145
pubmed: 28424068
Behav Modif. 2019 Jan;43(1):26-55
pubmed: 29047288
Clin Psychol Rev. 2015 Dec;42:168-78
pubmed: 26431668
BMC Psychiatry. 2014 Dec 14;14:355
pubmed: 25496393
Front Psychiatry. 2019 Apr 09;10:180
pubmed: 31024352
Cogn Behav Ther. 2018 Jan;47(1):1-18
pubmed: 29215315
Internet Interv. 2017 Sep 22;10:29-38
pubmed: 30135750
Ann Intern Med. 2007 Mar 6;146(5):317-25
pubmed: 17339617
Cogn Behav Ther. 2017 Jan;46(1):29-43
pubmed: 27705086
J Consult Clin Psychol. 2004 Aug;72(4):653-9
pubmed: 15301650
Br J Clin Psychol. 2010 Nov;49(Pt 4):491-505
pubmed: 19878622
J Pers. 2001 Aug;69(4):617-40
pubmed: 11497032
Am Psychol. 2010 Feb-Mar;65(2):73-84
pubmed: 20141263
Clin Psychol Rev. 2015 Aug;40:91-110
pubmed: 26094079
Clin Psychol Rev. 2011 Nov;31(7):1117-25
pubmed: 21820991
Drug Alcohol Rev. 2010 Nov;29(6):617-22
pubmed: 20973846
Psychol Med. 2007 Mar;37(3):319-28
pubmed: 17112400